AAAAAA
Results:
1-12
|
Results: 12
Authors:
De Windt, LJ
Willems, J
Roemen, THM
Coumans, WA
Reneman, RS
Van der Vusse, GJ
Van Bilsen, M
Citation: Lj. De Windt et al., Ischemic-reperfused isolated working mouse hearts: membrane damage and type IIA phospholipase A(2), AM J P-HEAR, 280(6), 2001, pp. H2572-H2580
Authors:
De Windt, LJ
Lim, HW
Bueno, OF
Liang, QR
Delling, U
Braz, JC
Glascock, BJ
Kimball, TF
del Monte, F
Hajjar, RJ
Molkentin, JD
Citation: Lj. De Windt et al., Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo, P NAS US, 98(6), 2001, pp. 3322-3327
Authors:
Liang, QR
De Windt, LJ
Witt, SA
Kimball, TR
Markham, BE
Molkentin, JD
Citation: Qr. Liang et al., The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo, J BIOL CHEM, 276(32), 2001, pp. 30245-30253
The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo
Authors:
Bueno, OF
De Windt, LJ
Lim, HW
Tymitz, KM
Witt, SA
Kimball, TR
Molkentin, JD
Citation: Of. Bueno et al., The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo, CIRCUL RES, 88(1), 2001, pp. 88-96
Authors:
Delling, U
Tureckova, J
Lim, HW
De Windt, LJ
Rotwein, P
Molkentin, JD
Citation: U. Delling et al., A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression, MOL CELL B, 20(17), 2000, pp. 6600-6611
Authors:
Bueno, OF
De Windt, LJ
Tymitz, KM
Witt, SA
Kimball, TR
Klevitsky, R
Hewett, TE
Jones, SP
Lefer, DJ
Peng, CF
Kitsis, RN
Molkentin, JD
Citation: Of. Bueno et al., The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophyin transgenic mice, EMBO J, 19(23), 2000, pp. 6341-6350
Authors:
Taigen, T
De Windt, LJ
Lim, HW
Molkentin, JD
Citation: T. Taigen et al., Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy, P NAS US, 97(3), 2000, pp. 1196-1201
Authors:
Lim, HW
De Windt, LJ
Mante, J
Kimball, TR
Witt, SA
Sussman, MA
Molkentin, JD
Citation: Hw. Lim et al., Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition, J MOL CEL C, 32(4), 2000, pp. 697-709
Authors:
De Windt, LJ
Lim, HW
Haq, S
Force, T
Molkentin, JD
Citation: Lj. De Windt et al., Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart - Cross-talk between cardiac hypertrophic signaling pathways, J BIOL CHEM, 275(18), 2000, pp. 13571-13579
Authors:
De Windt, LJ
Lim, HW
Taigen, T
Wencker, D
Condorelli, G
Dorn, GW
Kitsis, RN
Molkentin, JD
Citation: Lj. De Windt et al., Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis invitro and in vivo - An apoptosis-independent model of dilated heart failure, CIRCUL RES, 86(3), 2000, pp. 255-263
Authors:
Lim, HW
De Windt, LJ
Steinberg, L
Taigen, T
Witt, SA
Kimball, TR
Molkentin, JD
Citation: Hw. Lim et al., Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy, CIRCULATION, 101(20), 2000, pp. 2431-2437
Authors:
De Windt, LJ
Willems, J
Reneman, RS
Van der Vusse, GJ
Arts, T
Van Bilsen, M
Citation: Lj. De Windt et al., An improved isolated, left ventricular ejecting, murine heart model - Functional and metabolic evaluation, PFLUG ARCH, 437(2), 1999, pp. 182-190
Risultati:
1-12
|